Listar MD - Artículos por autor "Domenech, Montserrat"
Mostrando ítems 1-2 de 2
-
Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study
Aparicio, Jorge; Maroto, Pablo; García del Muro, Xavier; Guma, Josep; Sánchez-Muñoz, Alfonso
; Margelí, Mireia; Domenech, Montserrat; Bastús, Romá; Fernández, Antonio; Lopez-Brea, Marta; Terrassa, Josefa; Meana, Andrés; Martínez del Prado, Purificación; Sastre, Javier; Satrustegui, Juan J.; Girones, Regina; Robert, Lidia; Germa, José R.[et al.] (Editorial Roster. ASCO publications, 2011-10)
Purpose To confirm the efficacy of a risk-adapted treatment approach for patients with clinical stage I seminoma. The aim was to reduce both the risk of relapse and the proportion of patients receiving adjuvant chemotherapy ... -
Treatment and outcome of patients with stage IS testicular cancer: a retrospective study from the Spanish Germ Cell Cancer Group.
Aparicio, Jorge; Sánchez-Muñoz, Alfonso; Ochenduszko, Sebastian; Guma, Josep; Fernández-Aramburo, Antonio; García del Muro, Xavier; Quiroga, Vanesa; Sastre, Javier; Alonso-Gordoa, Teresa; Sagastibelza, Naiara; Maroto, Pablo; Gómez-de-Liaño, Alfonso; Vázquez, Sergio; Diz, P.; Durán, Ignacio; Domenech, Montserrat; Pinto, Álvaro; Hernández, Amaia; González-Billalabeitia, Enrique; Terrasa, Josefa[et al.] (Lippincott, Williams & Wilkins, 2019)
Stage IS testicular cancer is defined by the persistence of elevated serum tumor markers, including α-fetoprotein and/or β-human chorionic gonadotropin, after orchiectomy without radiological evidence of metastatic disease. ...